Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients

Mendez, Liliana S. C.; Nita, Marcelo E.; Ono-Nita, Suzane K.; Mello, Evandro S.; Da Silva, Luiz Caetano; Alves, Venâncio A. F.; Carrilho, Flair J.; Reshetnyak, Vasiliy I.
April 2008
World Journal of Gastroenterology;4/28/2008, Vol. 14 Issue 16, p2522
Academic Journal
AIM: To evaluate the epidemiological, clinical, laboratory and histological variables capable of predicting the progression of hepatic structural disturbances in chronic hepatitis C patients during the time interval between two liver biopsies. METHODS: Clinical charts of 112 chronic hepatitis C patients were retrospectively analyzed, whereas liver biopsies were revised. Immunohistochemical detection of interferon receptor was based on the Envision-Peroxidase System. RESULTS: In the multivariate analysis, the variables in the age at first biopsy, ALT levels, presence of lymphoid aggregates and siderosis were the determinants of the best model for predicting the severity of the disease. The direct progression rate of hepatic structural lesions was significantly higher in untreated patients, intermediate in treated non-responders and lower in treated responders to antiviral therapy (non-treated vs responders, 0.22 ± 0.50 vs -0.15 ± 0.46, P = 0.0053). Immuno-expression of interferon receptor is not a relevant factor. CONCLUSION: The best predictors of the progression of fibrosis are age at the first liver biopsy, extent of ALT elevation, inflammation at liver histology and hepatic siderosis. Antiviral treatment is effective in preventing the progression of liver structural lesions in chronic hepatitis C patients.


Related Articles

  • Hepatitis C Virus Clearance after Discontinuation of Pegylated Interferon Alpha-2a Monotherapy in a Child. Takeshi Endo; Koichi Ito; Tokio Sugiura; Kenji Goto // Case Reports in Medicine;2012, p1 

    The present patient was a 4-year-old boy. His hepatitis C virus genotype was 2a, and his viral load was high (1400,000 U/mL). The pretreatment liver biopsy revealed no fibrosis or malignancy and mild chronic hepatitis; his Knodell's histological activity (HAI) score was 4. Single nucleotide...

  • Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Regev, Arie; Berho, Mariana; Jeffers, Lennox J.; Milikowski, Clara; Molina, Enrique G.; Pyrsopoulos, Nikolaos T.; Feng, Zheng-Zhou; Reddy, K. Rajender; Schiff, Eugene R. // American Journal of Gastroenterology;Oct2002, Vol. 97 Issue 10, p2614 

    OBJECTIVES:Needle liver biopsy has been shown to have a high rate of sampling error in patients with diffuse parenchymal liver diseases. In these cases, the sample of liver tissue does not reflect the true degree of inflammation, fibrosis, or cirrhosis, despite an adequate sample size. The aim...

  • Spectrum of disease in U.S. veteran patients with hepatitis C. Nguyen, Huy A.; Miller, April I.; Dieperink, Eric; Willenbring, Mark L.; Tetrick, Lori L.; Durfee, Janet M.; Ewing, Stephen L.; Ho, Samuel B. // American Journal of Gastroenterology;Jul2002, Vol. 97 Issue 7, p1813 

    OBJECTIVE:Hepatitis C virus (HCV) infection is more prevalent in U.S. veterans attending Veterans Affairs Medical Centers than in the general population. The purpose of this study was to examine the risk factors, psychiatric and substance abuse conditions, and severity of liver disease in...

  • Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study. Gordon, Stuart C; Lamerato, Lois E; Rupp, Loralee B; Holmberg, Scott D; Moorman, Anne C; Spradling, Philip R; Teshale, Eyasu; Xu, Fujie; Boscarino, Joseph A; Vijayadeva, Vinutha; Schmidt, Mark A; Oja-Tebbe, Nancy; Lu, Mei // American Journal of Gastroenterology;Aug2015, Vol. 110 Issue 8, p1169 

    Objectives:The severity of liver disease in the hepatitis C virus (HCV)-infected population in the United States remains uncertain. We estimated the prevalence of cirrhosis in adults with chronic hepatitis C (CHC) using multiple parameters including liver biopsy, diagnosis/procedure codes, and a...

  • Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C. Morikawa, Hiroyasu; Fukuda, Katsuhiko; Kobayashi, Sawako; Fujii, Hideki; Iwai, Shuji; Enomoto, Masaru; Tamori, Akihiro; Sakaguchi, Hiroki; Kawada, Norifumi // Journal of Gastroenterology;Mar2011, Vol. 46 Issue 3, p350 

    Background : Although histopathological examination by 'invasive' liver biopsy remains the gold standard for evaluating disease progression in chronic liver disease, noninvasive tools have appeared and have led to great progress in diagnosing the stage of hepatic fibrosis. The aim of this study...

  • Liver Stiffness Measurement Versus Clinicians' Prediction or Both for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C. Nahon, Pierre; Thabut, Gabriel; Ziol, Marianne; Tin-Tin Htar, Myint; Cesaro, Fabien; Barget, Nathalie; Grando-Lemaire, Véronique; Ganne-Carrie, Nathalie; Trinchet, Jean-Claude; Beaugrand, Michel // American Journal of Gastroenterology;Dec2006, Vol. 101 Issue 12, p2744 

    OBJECTIVES: The goal of this study was to estimate the additional value of liver stiffness measurement (LSM) with physicians' assessment of fibrosis based on epidemiological, clinical, and biological parameters. METHODS: One hundred forty-two unselected patients with chronic hepatitis C were...

  • Hemobilia and Melena After Liver Biopsy: A Case Report and Review of Literature. Emara, Mohamed H.; Ibrahim, Ibrahim M.; Radwan, Mohamed I.; Abd Elbast, Mohamed R. // Gastroenterology Research;Oct2013, Vol. 6 Issue 5, p200 

    Liver biopsy is the gold standard for assessment of hepatic fibrosis although it is associated with many complications. We reported a 28-year-old chronic HCV patient who developed gall bladder hematoma with hemobilia and melena after liver biopsy. The hematoma resolved with conservative management.

  • Association of steatosis with histopathological grading and staging of liver biopsies in hepatitis C patients. Syed, Shuja Izhar; Sadiq, Saleem // Pakistan Journal of Medical Sciences;Apr2011, Vol. 27 Issue 3, p638 

    Objective: To find out the association of steatosis with histopathological grading and staging of liver biopsies in hepatitis C patients. Methodology: This was a prospective study based on liver biopsies of hepatitis C patients. H and E stained slides were examined to determine the histological...

  • Prospective Non-Invasive Follow-up of Liver Fibrosis in Patients with Chronic hepatitis C. Crisan, Dana; Radu, Corina; Dan Grigorescu, Mircea; Lupsor, Monica; Feier, Diana; Grigorescu, Mircea // Journal of Gastrointestinal & Liver Diseases;Dec2012, Vol. 21 Issue 4, p375 

    Background: Non-invasive methods for the assessment of liver fibrosis are accurate in staging chronic liver diseases before treatment. Aim: To prospectively assess liver fibrosis in chronic hepatitis C (CHC) in patients treated vs untreated, using non-invasive methods. Method: 224 patients with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics